PMID- 35259393 OWN - NLM STAT- MEDLINE DCOM- 20220621 LR - 20230703 IS - 1097-6779 (Electronic) IS - 0016-5107 (Print) IS - 0016-5107 (Linking) VI - 96 IP - 1 DP - 2022 Jul TI - Endoscopic gastric plication for the treatment of weight regain after Roux-en-Y gastric bypass (with video). PG - 51-56 LID - S0016-5107(22)00190-0 [pii] LID - 10.1016/j.gie.2022.02.051 [doi] AB - BACKGROUND AND AIMS: Gastric plication involves inverting the stomach with tissue anchor placement to achieve serosa-to-serosa apposition. One potential application of gastric plication is the treatment of weight regain after Roux-en-Y gastric bypass (RYGB), a procedure also known as plication transoral outlet reduction (P-TORe). This study aims to assess technical feasibility, safety, and efficacy of P-TORe. METHODS: This was a registry study of RYGB patients who underwent P-TORe for weight regain. The primary outcome was the amount of weight loss and clinical success rate, defined as percentage of total weight loss (TWL) of at least 5% at 12 months. Secondary outcomes were technical success, adverse events (AEs), and predictors of weight loss. RESULTS: One hundred eleven RYGB patients underwent P-TORe. Average body mass index (BMI) was 38.5 +/- 7.5 kg/m(2). Baseline gastrojejunal anastomosis (GJA) and pouch sizes were 17 +/- 6 mm and 5 +/- 2 cm, respectively. The primary outcome was total weight loss, defined as patients experiencing 9.5% +/- 8.5% TWL at 12 months. Clinical success rate was 73%. Technical success rate was 100%. Argon plasma coagulation (APC) was performed around the GJA in all patients (100%) before plication placement. The total number of plications per case was 7 +/- 3. Overall AE rate was 12.6%. These included GJA stenosis (9.9%), melena because of marginal ulceration (1.8%), and deep vein thrombosis (.9%). The severe AE rate was 0%. Predictors of weight loss were the amount of weight regain and baseline pouch length. CONCLUSIONS: This novel P-TORe technique combining APC with gastric plication appears to be technically feasible, safe, and effective at treating weight regain after RYGB. CI - Copyright (c) 2022 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved. FAU - Jirapinyo, Pichamol AU - Jirapinyo P AD - Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA. FAU - Thompson, Christopher C AU - Thompson CC AD - Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA. LA - eng GR - P30 DK034854/DK/NIDDK NIH HHS/United States GR - T32 DK007533/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Video-Audio Media DEP - 20220305 PL - United States TA - Gastrointest Endosc JT - Gastrointestinal endoscopy JID - 0010505 SB - IM MH - Anastomosis, Roux-en-Y MH - *Gastric Bypass/adverse effects MH - Humans MH - *Obesity, Morbid/surgery MH - Reoperation/methods MH - Retrospective Studies MH - Stomach/surgery MH - Treatment Outcome MH - Weight Gain MH - Weight Loss PMC - PMC9233122 MID - NIHMS1809312 EDAT- 2022/03/09 06:00 MHDA- 2022/06/22 06:00 PMCR- 2023/07/01 CRDT- 2022/03/08 20:10 PHST- 2021/10/22 00:00 [received] PHST- 2022/02/15 00:00 [accepted] PHST- 2022/03/09 06:00 [pubmed] PHST- 2022/06/22 06:00 [medline] PHST- 2022/03/08 20:10 [entrez] PHST- 2023/07/01 00:00 [pmc-release] AID - S0016-5107(22)00190-0 [pii] AID - 10.1016/j.gie.2022.02.051 [doi] PST - ppublish SO - Gastrointest Endosc. 2022 Jul;96(1):51-56. doi: 10.1016/j.gie.2022.02.051. Epub 2022 Mar 5.